Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2023 | 4 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy.
Cancers (Basel). 2023 Jul 25;15(15):3767. doi: 10.3390/cancers15153767.
Cancers (Basel). 2023.
PMID: 37568582
Free PMC article.
Review.
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR.
Ploeg EM, Samplonius DF, Xiong X, Ke X, Hendriks MAJM, Britsch I, van Wijngaarden AP, Zhang H, Helfrich W.
Ploeg EM, et al. Among authors: britsch i.
J Immunother Cancer. 2023 Sep;11(9):e006837. doi: 10.1136/jitc-2023-006837.
J Immunother Cancer. 2023.
PMID: 37734877
Free PMC article.
Item in Clipboard
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells.
Britsch I, van Wijngaarden AP, Ke X, Hendriks MAJM, Samplonius DF, Ploeg EM, Helfrich W.
Britsch I, et al.
Oncoimmunology. 2023 May 10;12(1):2207868. doi: 10.1080/2162402X.2023.2207868. eCollection 2023.
Oncoimmunology. 2023.
PMID: 37180637
Free PMC article.
Item in Clipboard
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer.
Ploeg EM, Britsch I, van Wijngaarden AP, Ke X, Hendriks MAJM, Samplonius DF, Helfrich W.
Ploeg EM, et al. Among authors: britsch i.
Cancers (Basel). 2023 Jul 17;15(14):3651. doi: 10.3390/cancers15143651.
Cancers (Basel). 2023.
PMID: 37509310
Free PMC article.
Item in Clipboard
Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles.
Ploeg EM, Ke X, Britsch I, Hendriks MAJM, Van der Zant FA, Kruijff S, Samplonius DF, Zhang H, Helfrich W.
Ploeg EM, et al. Among authors: britsch i.
Cancer Lett. 2021 Aug 28;521:109-118. doi: 10.1016/j.canlet.2021.08.037. Online ahead of print.
Cancer Lett. 2021.
PMID: 34464670
Free article.
Item in Clipboard
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis.
Hendriks MAJM, Britsch I, Ke X, van Wijngarden AP, Samplonius DF, Ploeg EM, Helfrich W.
Hendriks MAJM, et al. Among authors: britsch i.
Oncoimmunology. 2021 Nov 20;10(1):2005344. doi: 10.1080/2162402X.2021.2005344. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34858730
Free PMC article.
Item in Clipboard
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation.
Hendriks MAJM, Ploeg EM, Koopmans I, Britsch I, Ke X, Samplonius DF, Helfrich W.
Hendriks MAJM, et al. Among authors: britsch i.
Oncoimmunology. 2020 Sep 29;9(1):1824323. doi: 10.1080/2162402X.2020.1824323.
Oncoimmunology. 2020.
PMID: 33299654
Free PMC article.
Item in Clipboard
Cite
Cite